HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-NOV-18 6N3O
TITLE IDENTIFICATION OF NOVEL, POTENT AND SELECTIVE GCN2 INHIBITORS AS
TITLE 2 FIRST-IN-CLASS ANTI-TUMOR AGENTS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: EIF-2-ALPHA KINASE GCN2;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4,
COMPND 5 GCN2-LIKE PROTEIN,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA
COMPND 6 KINASE 4,GCN2-LIKE PROTEIN;
COMPND 7 EC: 2.7.11.1;
COMPND 8 ENGINEERED: YES;
COMPND 9 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: EIF2AK4, GCN2, KIAA1338;
SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469;
SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9
KEYWDS GCN2, KINASE, INHIBITOR, ANTI-TUMOR, TRANSFERASE-TRANSFERASE
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR I.D.HOFFMAN,J.FUJIMOTO,O.KURASAWA,T.TAKAGI,M.G.KLEIN,G.KEFALA,
AUTHOR 2 S.C.DING,D.R.CARY,R.MIZOJIRI
REVDAT 3 13-MAR-24 6N3O 1 REMARK
REVDAT 2 30-OCT-19 6N3O 1 JRNL
REVDAT 1 09-OCT-19 6N3O 0
JRNL AUTH J.FUJIMOTO,O.KURASAWA,T.TAKAGI,X.LIU,H.BANNO,T.KOJIMA,
JRNL AUTH 2 Y.ASANO,A.NAKAMURA,T.NAMBU,A.HATA,T.ISHII,T.SAMESHIMA,
JRNL AUTH 3 Y.DEBORI,M.MIYAMOTO,M.G.KLEIN,R.TJHEN,B.C.SANG,I.LEVIN,
JRNL AUTH 4 S.W.LANE,G.P.SNELL,K.LI,G.KEFALA,I.D.HOFFMAN,S.C.DING,
JRNL AUTH 5 D.R.CARY,R.MIZOJIRI
JRNL TITL IDENTIFICATION OF NOVEL, POTENT, AND ORALLY AVAILABLE GCN2
JRNL TITL 2 INHIBITORS WITH TYPE I HALF BINDING MODE.
JRNL REF ACS MED.CHEM.LETT. V. 10 1498 2019
JRNL REFN ISSN 1948-5875
JRNL PMID 31620240
JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00400
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 15338
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.202
REMARK 3 R VALUE (WORKING SET) : 0.199
REMARK 3 FREE R VALUE : 0.254
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900
REMARK 3 FREE R VALUE TEST SET COUNT : 796
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2069
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 30
REMARK 3 SOLVENT ATOMS : 17
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 84.30
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.65000
REMARK 3 B22 (A**2) : 0.65000
REMARK 3 B33 (A**2) : -2.10000
REMARK 3 B12 (A**2) : 0.32000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.270
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.231
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.214
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.225
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS U VALUES : WITH TLS ADDED
REMARK 4
REMARK 4 6N3O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-18.
REMARK 100 THE DEPOSITION ID IS D_1000238124.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-APR-16
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 5.0.2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16229
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400
REMARK 200 RESOLUTION RANGE LOW (A) : 48.430
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 18.60
REMARK 200 R MERGE (I) : 0.09900
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 19.60
REMARK 200 R MERGE FOR SHELL (I) : 3.62100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.64
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM NA CITRATE PH 5.6, 8% PEG 6K,
REMARK 280 0.7 M LICL, 1% ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+5/6
REMARK 290 6555 X-Y,X,Z+1/6
REMARK 290 7555 Y,X,-Z+1/3
REMARK 290 8555 X-Y,-Y,-Z
REMARK 290 9555 -X,-X+Y,-Z+2/3
REMARK 290 10555 -Y,-X,-Z+5/6
REMARK 290 11555 -X+Y,Y,-Z+1/2
REMARK 290 12555 X,X-Y,-Z+1/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.56733
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 129.13467
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 96.85100
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 161.41833
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 32.28367
REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 64.56733
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 129.13467
REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 161.41833
REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 96.85100
REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 32.28367
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 574
REMARK 465 GLY A 575
REMARK 465 SER A 576
REMARK 465 SER A 577
REMARK 465 GLU A 578
REMARK 465 THR A 579
REMARK 465 GLN A 580
REMARK 465 ARG A 581
REMARK 465 GLN A 582
REMARK 465 PHE A 583
REMARK 465 GLY A 782
REMARK 465 CYS A 783
REMARK 465 HIS A 784
REMARK 465 GLU A 785
REMARK 465 SER A 786
REMARK 465 GLU A 787
REMARK 465 PRO A 788
REMARK 465 SER A 789
REMARK 465 VAL A 790
REMARK 465 THR A 791
REMARK 465 THR A 792
REMARK 465 GLU A 793
REMARK 465 ALA A 878
REMARK 465 ASP A 879
REMARK 465 SER A 880
REMARK 465 LYS A 881
REMARK 465 GLN A 882
REMARK 465 ASP A 883
REMARK 465 ASP A 884
REMARK 465 GLN A 885
REMARK 465 THR A 886
REMARK 465 GLY A 887
REMARK 465 ASP A 888
REMARK 465 LEU A 889
REMARK 465 ILE A 890
REMARK 465 LYS A 891
REMARK 465 SER A 892
REMARK 465 ASP A 893
REMARK 465 PRO A 894
REMARK 465 SER A 895
REMARK 465 GLY A 896
REMARK 465 HIS A 897
REMARK 465 LEU A 898
REMARK 465 GLU A 899
REMARK 465 GLY A 900
REMARK 465 MET A 901
REMARK 465 VAL A 902
REMARK 465 GLY A 903
REMARK 465 VAL A 912
REMARK 465 GLN A 913
REMARK 465 GLY A 914
REMARK 465 SER A 915
REMARK 465 THR A 916
REMARK 465 LYS A 917
REMARK 465 SER A 918
REMARK 465 ALA A 919
REMARK 465 GLN A 1005
REMARK 465 MET A 1006
REMARK 465 GLU A 1007
REMARK 465 GLU A 1008
REMARK 465 SER A 1009
REMARK 465 GLU A 1010
REMARK 465 LEU A 1011
REMARK 465 HIS A 1012
REMARK 465 GLU A 1013
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 626 -4.37 92.55
REMARK 500 SER A 808 -145.86 65.84
REMARK 500 ARG A 847 -15.13 76.04
REMARK 500 GLN A 922 -30.90 -38.01
REMARK 500 SER A 959 136.50 74.97
REMARK 500 ASP A 967 72.85 -63.65
REMARK 500 HIS A 971 49.53 -109.70
REMARK 500 GLU A 999 31.52 -95.68
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue KA7 A 2500
DBREF 6N3O A 577 657 UNP Q9P2K8 E2AK4_HUMAN 577 657
DBREF 6N3O A 658 1013 UNP Q9P2K8 E2AK4_HUMAN 781 1013
SEQADV 6N3O GLY A 574 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3O GLY A 575 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3O SER A 576 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3O ALA A 807 UNP Q9P2K8 LYS 807 ENGINEERED MUTATION
SEQADV 6N3O ASN A 848 UNP Q9P2K8 ASP 848 ENGINEERED MUTATION
SEQADV 6N3O GLU A 899 UNP Q9P2K8 THR 899 ENGINEERED MUTATION
SEQADV 6N3O GLU A 904 UNP Q9P2K8 THR 904 ENGINEERED MUTATION
SEQRES 1 A 317 GLY GLY SER SER GLU THR GLN ARG GLN PHE SER ARG TYR
SEQRES 2 A 317 PHE ILE GLU PHE GLU GLU LEU GLN LEU LEU GLY LYS GLY
SEQRES 3 A 317 ALA PHE GLY ALA VAL ILE LYS VAL GLN ASN LYS LEU ASP
SEQRES 4 A 317 GLY CYS CYS TYR ALA VAL LYS ARG ILE PRO ILE ASN PRO
SEQRES 5 A 317 ALA SER ARG GLN PHE ARG ARG ILE LYS GLY GLU VAL THR
SEQRES 6 A 317 LEU LEU SER ARG LEU HIS HIS GLU ASN ILE VAL ARG TYR
SEQRES 7 A 317 TYR ASN ALA TRP ILE GLU ASN GLY CYS HIS GLU SER GLU
SEQRES 8 A 317 PRO SER VAL THR THR GLU ALA VAL HIS TYR LEU TYR ILE
SEQRES 9 A 317 GLN MET GLU TYR CYS GLU ALA SER THR LEU ARG ASP THR
SEQRES 10 A 317 ILE ASP GLN GLY LEU TYR ARG ASP THR VAL ARG LEU TRP
SEQRES 11 A 317 ARG LEU PHE ARG GLU ILE LEU ASP GLY LEU ALA TYR ILE
SEQRES 12 A 317 HIS GLU LYS GLY MET ILE HIS ARG ASN LEU LYS PRO VAL
SEQRES 13 A 317 ASN ILE PHE LEU ASP SER ASP ASP HIS VAL LYS ILE GLY
SEQRES 14 A 317 ASP PHE GLY LEU ALA THR ASP HIS LEU ALA PHE SER ALA
SEQRES 15 A 317 ASP SER LYS GLN ASP ASP GLN THR GLY ASP LEU ILE LYS
SEQRES 16 A 317 SER ASP PRO SER GLY HIS LEU GLU GLY MET VAL GLY GLU
SEQRES 17 A 317 ALA LEU TYR VAL SER PRO GLU VAL GLN GLY SER THR LYS
SEQRES 18 A 317 SER ALA TYR ASN GLN LYS VAL ASP LEU PHE SER LEU GLY
SEQRES 19 A 317 ILE ILE PHE PHE GLU MET SER TYR HIS PRO MET VAL THR
SEQRES 20 A 317 ALA SER GLU ARG ILE PHE VAL LEU ASN GLN LEU ARG ASP
SEQRES 21 A 317 PRO THR SER PRO LYS PHE PRO GLU ASP PHE ASP ASP GLY
SEQRES 22 A 317 GLU HIS ALA LYS GLN LYS SER VAL ILE SER TRP LEU LEU
SEQRES 23 A 317 ASN HIS ASP PRO ALA LYS ARG PRO THR ALA THR GLU LEU
SEQRES 24 A 317 LEU LYS SER GLU LEU LEU PRO PRO PRO GLN MET GLU GLU
SEQRES 25 A 317 SER GLU LEU HIS GLU
HET KA7 A2500 30
HETNAM KA7 N-{3-[(2-AMINOPYRIMIDIN-5-YL)ETHYNYL]-2,4-
HETNAM 2 KA7 DIFLUOROPHENYL}-5-CHLORO-2-METHOXYPYRIDINE-3-
HETNAM 3 KA7 SULFONAMIDE
FORMUL 2 KA7 C18 H12 CL F2 N5 O3 S
FORMUL 3 HOH *17(H2 O)
HELIX 1 AA1 SER A 584 GLU A 589 1 6
HELIX 2 AA2 SER A 627 SER A 641 1 15
HELIX 3 AA3 THR A 809 GLN A 816 1 8
HELIX 4 AA4 GLY A 817 ARG A 820 5 4
HELIX 5 AA5 ASP A 821 LYS A 842 1 22
HELIX 6 AA6 LYS A 850 VAL A 852 5 3
HELIX 7 AA7 LYS A 923 TYR A 938 1 16
HELIX 8 AA8 THR A 943 ARG A 955 1 13
HELIX 9 AA9 HIS A 971 LEU A 982 1 12
HELIX 10 AB1 ASP A 985 ARG A 989 5 5
HELIX 11 AB2 THR A 991 SER A 998 1 8
SHEET 1 AA1 5 PHE A 590 GLY A 599 0
SHEET 2 AA1 5 GLY A 602 ASN A 609 -1 O VAL A 604 N LEU A 596
SHEET 3 AA1 5 CYS A 615 PRO A 622 -1 O VAL A 618 N ILE A 605
SHEET 4 AA1 5 TYR A 797 GLU A 803 -1 O MET A 802 N ALA A 617
SHEET 5 AA1 5 TYR A 651 GLU A 657 -1 N ASN A 653 O GLN A 801
SHEET 1 AA2 2 ILE A 854 LEU A 856 0
SHEET 2 AA2 2 VAL A 862 ILE A 864 -1 O LYS A 863 N PHE A 855
SITE 1 AC1 17 LEU A 596 VAL A 604 ALA A 617 LYS A 619
SITE 2 AC1 17 LEU A 640 ILE A 648 VAL A 649 TYR A 651
SITE 3 AC1 17 MET A 802 GLU A 803 TYR A 804 CYS A 805
SITE 4 AC1 17 PHE A 855 ASP A 866 PHE A 867 HOH A2604
SITE 5 AC1 17 HOH A2610
CRYST1 82.899 82.899 193.702 90.00 90.00 120.00 P 61 2 2 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.012063 0.006965 0.000000 0.00000
SCALE2 0.000000 0.013929 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005163 0.00000